首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
【24h】

Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.

机译:胰多肽折叠肽受体和血管紧张素II诱导的肾血管收缩。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The Gi pathway augments renal vasoconstriction induced by angiotensin II in spontaneously hypertensive but not normotensive Wistar-Kyoto rats. Because the Gi-coupled pancreatic polypeptide (PP)-fold peptide receptors Y1 and Y2 are expressed in kidneys and are activated by endogenous PP-fold peptides, we tested the hypothesis that these receptors regulate angiotensin II-induced renal vasoconstriction in kidneys from hypertensive but not normotensive rats. A selective Y1-receptor agonist [(Leu31,Pro34)-neuropeptide Y; 6 to 10 nmol/L] greatly potentiated angiotensin II-induced changes in perfusion pressure in isolated, perfused kidneys from hypertensive but not normotensive rats. A selective Y2-receptor agonist (peptide YY(3-36); 6 nM) only slightly potentiated angiotensin II-induced renal vasoconstriction and only in kidneys from hypertensive rats. Neither the Y1-receptor nor the Y2-receptor agonist increased basal perfusion pressure. BIBP3226 (1 micromol/L, highly selective Y1-receptor antagonist) and BIIE0246 (1 micromol/L, highly selective Y2-receptor antagonist) completely abolished potentiation by (Leu31,Pro34)-neuropeptide Y and peptide YY(3-36), respectively. Y1-receptor and Y2-receptor mRNA and protein levels were expressed in renal microvessels and whole kidneys, but the abundance was similar in kidneys from hypertensive and normotensive rats. Both Y1-receptor-induced and Y2-receptor-induced potentiation of angiotensin II-mediated renal vasoconstriction was completely abolished by pretreatment with pertussis toxin (30 microg/kg IV, blocks Gi proteins). These data indicate that, in kidneys from genetically hypertensive but not normotensive rats, Y1-receptor activation markedly enhances angiotensin II-mediated renal vasoconstriction by a mechanism involving Gi. Although Y2 receptors can also potentiate angiotensin II-mediated renal vasoconstriction via Gi, the effect is modest compared with Y1 receptors. These findings may have important implications for the etiology of genetic hypertension.
机译:Gi通路增强了自发性高血压而非正常血压的Wistar-Kyoto大鼠的血管紧张素II诱导的肾血管收缩。因为Gi偶联的胰多肽(PP)折叠肽受体Y1和Y2在肾脏中表达并被内源PP折叠肽激活,所以我们测试了以下假设:这些受体调节高血压引起的肾脏中血管紧张素II诱导的肾血管收缩不是血压正常的大鼠。选择性Y1受体激动剂[(Leu31,Pro34)-神经肽Y; [6至10 nmol / L]可以大大增强血管紧张素II诱导的高血压大鼠(而非正常血压大鼠)的孤立,灌注肾脏中的灌注压力变化。选择性Y2受体激动剂(肽YY(3-36); 6 nM)仅在血管紧张素II诱导的肾血管收缩中具有轻微增强作用,并且仅在高血压大鼠的肾脏中起作用。 Y1受体或Y2受体激动剂均不会增加基础灌注压力。 BIBP3226(1 micromol / L,高度选择性的Y1-受体拮抗剂)和BIIE0246(1 micromol / L,高度选择性的Y2-受体拮抗剂)完全消除了(Leu31,Pro34)-神经肽Y和肽YY(3-36)的增强作用,分别。 Y1受体和Y2受体mRNA和蛋白水平在肾脏微血管和整个肾脏中表达,但在高血压和正常血压大鼠的肾脏中,丰度相似。百日咳毒素(30微克/千克静脉注射,阻断Gi蛋白)预处理可完全消除血管紧张素II介导的肾血管收缩的Y1受体诱导和Y2受体诱导的增强作用。这些数据表明,在来自遗传性高血压而非正常血压大鼠的肾脏中,Y1受体激活通过涉及Gi的机制显着增强了血管紧张素II介导的肾血管收缩。尽管Y2受体也可以通过Gi增强血管紧张素II介导的肾血管收缩,但与Y1受体相比,这种作用并不明显。这些发现可能对遗传性高血压的病因具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号